Monday, September 17, 2018

AstraZeneca sees positive trial for lung drug

  1. AstraZeneca sees positive trial for lung drug  MarketWatch
  2. AstraZeneca: KRONOS Phase III Trial Met Eight Of Nine Primary Endpoints  Markets InsiderFull coverage
(CLICK HERE TO READ AND SEE MORE

0 comments:

Post a Comment